Happy holidays!

The year is almost coming to an end. It is time to evaluate and enjoy all the achievements we have had, as well as the opportunities we have for growth and development.

This year, we started protocols in the following therapeutic indications:

  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma (RCC)
  • Melanoma
  • Chronic kidney disease
  • Migraine
  • Multiple sclerosis

And next year, hopefully, we are going to open more protocols in more indications as well.

This year has been of growth and learning new things. Some indications are new to us, so we have been adapting our patient recruitment strategies so we can enroll as many patients as possible. As a clinical research site, we are committed to reaching our recruitment goals, and providing with the best data for the sponsors, and care for our patients. We look forward to 2019 and we are very excited of the new projects coming along.

May next year be filled with love, growth, health, and joy. Happy holidays from the Althian team!